HLI is one of the most established, global longevity science companies and committed to accelerating living to 100+ years of a healthy, active, and mobile life

DUBAI, UAE and RIYADH, Saudi Arabia, Sept. 18, 2024 /PRNewswire/ -- TVM Capital Healthcare, an international healthcare expansion and growth capital firm, today announced a recent equity investment in San Francisco-based Human Longevity, Inc. (HLI), a global leader since 2013 in advancing precision medicine in the pursuit of healthy aging, often referred to as longevity medicine. The investment will support the company's growth within the U.S. market, as well as its expansion into the Kingdom of Saudi Arabia and Southeast Asia.

Register to unlock this article

Register to read this story and more for free.

Signing up for an account helps us improve your browsing experience.

Continue

OR

See our subscription options.

Already have an account? Log in here